Larson Financial Group
KYMR icon

Larson Financial Group’s Kymera Therapeutics KYMR Stock Holding History

Larson Financial Group’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$106K Sell
947
-8
-0.8% -$916 ﹤0.01% 1212
2026
Q2 		$110K Sell
955
-6
-0.6% -$516 ﹤0.01% 1137
2026
Q1 		$80K Sell
961
-103
-10% -$8.16K ﹤0.01% 1099
2025
Q4 		$82.8K Buy
1,064
+287
+37% +$19.4K ﹤0.01% 998
2025
Q3 		$44K Buy
777
+349
+82% +$15.7K ﹤0.01% 1215
2025
Q2 		$18.7K Buy
+428
New +$14.7K ﹤0.01% 1521

Other funds holding KYMR

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
TimesSquare Capital Management
TimesSquare Capital Management New York $6.12B AUM 30.01% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $25.3B AUM 15.9% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Larson Financial Group's KYMR Position: Q3 2026 in Review

Larson Financial Group reduced its Kymera Therapeutics (KYMR) stake by 0.84% in Q3 2026, selling an estimated $916 and leaving 947 shares worth $106K. The position accounts for ﹤0.01% of the portfolio, ranked #1212.

Larson Financial Group first reported a position in KYMR in Q2 2025 and has held it in 6 quarters since. The position peaked at $110K in Q2 2026. 110 funds tracked by Wall St. Rank hold KYMR as of Q3 2026.

  • Larson Financial Group held 947 shares of Kymera Therapeutics worth $106K as of Q3 2026.
  • Larson Financial Group sold 8 Kymera Therapeutics shares in Q3 2026, an estimated $916.
  • Kymera Therapeutics made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #1212 holding.
  • Larson Financial Group first reported a position in Kymera Therapeutics in Q2 2025 and has held it in 6 quarters since.
  • Larson Financial Group's Kymera Therapeutics position peaked at $110K in Q2 2026.
  • 110 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.